Devices › Apparatus, autotransfusion
Device brand name · Perioperative autotransfusion system
Orthopat Perioperative Autotransfusion System: medical device reports filed with FDA
1,016 reports name it, 2011–2016. Manufacturer given most often on reports: Haemonetics. Product code CAC.
- 1,016
- device reports naming the brand
- 0% of all MAUDE reports · about 66 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 99.5%
- classified as malfunction
- 80.1% across the product code
- 0.1%
- classified as death, as reported
- 1 reports · not verified by FDA
1,016 medical device reports received by FDA name the brand "Orthopat Perioperative Autotransfusion System" (perioperative autotransfusion system); the manufacturer given most often on reports is Haemonetics; received from January 2011 to November 2016. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (99.5%), injury (0.4%) and death (0.1%); across all apparatus, autotransfusion reports (product code CAC) death is recorded in 2.6% and malfunction in 80.1%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are device contamination with body fluid (30.6%), nonstandard device (14.7%) and failure to power up (9.7%). The patient problems coded most often are test result, blood loss and exposure to body fluids. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Orthopat Perioperative Autotransfusion System was received in the five years to August 2026; the latest was received in November 2016.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 3,172 reports carrying product code CAC. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Device contamination with body fluid | 311 | 30.6% | 10.5% |
| Nonstandard device | 149 | 14.7% | 5.6% |
| Failure to power up | 99 | 9.7% | 3.2% |
| Loss of powerthe device lost power | 80 | 7.9% | 2.7% |
| Fluid/blood leak | 71 | 7% | 12.2% |
| Device emits odor | 64 | 6.3% | 2.3% |
| Device displays incorrect message | 60 | 5.9% | 2.6% |
| Device operates differently than expectedthe device behaved unexpectedly | 59 | 5.8% | 4.7% |
| Breakthe device broke | 49 | 4.8% | 5.5% |
| Moisture damage | 47 | 4.6% | 1.7% |
| Leak/splashthe device leaked | 46 | 4.5% | 5.1% |
| Insufficient device problem information | 44 | 4.3% | 2.9% |
| Noise, audible | 41 | 4% | 2.4% |
| Electrical shorting | 32 | 3.1% | 1.2% |
| Smoking | 30 | 3% | 1.1% |
| Failure to charge | 28 | 2.8% | 0.9% |
| Device inoperablethe device could not be used | 19 | 1.9% | 2.1% |
| Device maintenance issue | 19 | 1.9% | 0.6% |
| Contamination | 14 | 1.4% | 0.7% |
| Device alarm system | 7 | 0.7% | 0.9% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Test result | 5 | 0.5% |
| Blood loss | 4 | 0.4% |
| Exposure to body fluids | 2 | 0.2% |
| Low blood pressure/ hypotension | 2 | 0.2% |
| Abdominal painstomach or belly pain | 1 | 0.1% |
| Cardiac arrestthe heart stopped | 1 | 0.1% |
| Deaththe patient died; cause not stated by this term | 1 | 0.1% |
| Hemorrhage/blood loss/bleeding | 1 | 0.1% |
| Needle stick/puncture | 1 | 0.1% |
| Rupturethe device burst | 1 | 0.1% |
| Vascular dissection | 1 | 0.1% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Orthopat Perioperative Autotransfusion System | Product code CAC | All MAUDE reports |
|---|---|---|---|
| Reports | 1,016 | 3,172 | 26,136,888 |
| Share of that pool | — | 32% | 0% |
| Classified as death, per 1,000 reports | 1 | 26 | 9 |
| Classified as injury | 0.4% | 14% | 36.2% |
| Classified as malfunction | 99.5% | 80.1% | 62.3% |
| Filed by the manufacturer | 100% | 90.5% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code CAC
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| autoLog Wash Kit | 160 | 46 | 0.6% |
| Argyle | 871 | 60 | 1% |
| Extraction Bag For Mis | 212 | 9 | 0% |
| Stryker | 559 | 5 | 1.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Orthopat Perioperative Autotransfusion System reports
How many FDA reports name Orthopat Perioperative Autotransfusion System?
1,016 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (99.5%), injury (0.4%) and death (0.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
device contamination with body fluid (30.6%), nonstandard device (14.7%), failure to power up (9.7%), loss of power (7.9%) and fluid/blood leak (7%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Orthopat Perioperative Autotransfusion System was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.